Two Case Reports of Resensitization to Previous Chemotherapy with the Novel Hypoxia-Activated Hypomethylating Anticancer Agent RRx-001 in Metastatic Colorectal Cancer Patients

Publisher： Karger

E-ISSN： 1662-6575|7|1|79-85

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.1, 2014-01, pp. : 79-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metastatic Castration-Resistant Prostate Cancer: Two Case Reports of Dramatic Response with Abiraterone Acetate in Patients Heavily Pretreated with Chemotherapy

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-06 ,pp. : 325-330

Karger

Access to resources Recommend Favorite

Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor

By  

Case Reports in Oncology, Vol. 8, Iss. 3, 2015-10 ,pp. : 461-465

Karger

Access to resources Recommend Favorite

Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab with Chemotherapy: The Gunma Clinical Oncology Group (GCOG) trial 001 SILK Study

By  

Oncology, Vol. 83, Iss. 3, 2012-08 ,pp. : 151-157

Karger

Access to resources Recommend Favorite

Chemotherapy-Induced Carcinoembryonic Antigen Surge in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 70, Iss. 1, 2006-03 ,pp. : 49-53

Karger

Access to resources Recommend Favorite

Hepatic Arterial Chemotherapy for Colorectal Cancer Metastatic to the Liver

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 89-97

Karger

Access to resources Recommend Favorite